AstraZeneca Admits Rare Clotting Risk—What They Knew in 2021

For the first time, AstraZeneca has legally acknowledged its COVID-19 vaccine’s link to rare clotting side effects—but is there more to the story? Dr. Muhin Sayyad delves into the legal documents, uncovering key admissions and a potential mechanism they were reportedly aware of as far back as December 2021. Coupled with shocking microscope footage of how different vaccines interact with blood cells, this video challenges the mainstream narrative and raises crucial questions about transparency and safety. Don’t miss this eye-opening investigation!